559 related articles for article (PubMed ID: 7818483)
1. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi.
Almeida IC; Ferguson MA; Schenkman S; Travassos LR
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):793-802. PubMed ID: 7818483
[TBL] [Abstract][Full Text] [Related]
2. GPI-anchored glycoconjugates from Trypanosoma cruzi trypomastigotes are recognized by lytic anti-alpha-galactosyl antibodies isolated from patients with chronic Chagas' disease.
Almeida IC; Ferguson MA; Schenkman S; Travassos LR
Braz J Med Biol Res; 1994 Feb; 27(2):443-7. PubMed ID: 8081263
[TBL] [Abstract][Full Text] [Related]
3. Glycoconjugates of Trypanosoma cruzi: a 74 kD antigen of trypomastigotes specifically reacts with lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas disease.
Almeida IC; Krautz GM; Krettli AU; Travassos LR
J Clin Lab Anal; 1993; 7(6):307-16. PubMed ID: 8277354
[TBL] [Abstract][Full Text] [Related]
4. Molecular mimicry between Trypanosoma cruzi and host nervous tissues.
Avila JL
Acta Cient Venez; 1992; 43(6):330-40. PubMed ID: 1343745
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Galα(1,3)Galβ(1,4)GlcNAcα-, Galβ(1,4)GlcNAcα- and GlcNAc-containing neoglycoproteins and their immunological evaluation in the context of Chagas disease.
Schocker NS; Portillo S; Brito CR; Marques AF; Almeida IC; Michael K
Glycobiology; 2016 Jan; 26(1):39-50. PubMed ID: 26384953
[TBL] [Abstract][Full Text] [Related]
6. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway.
Procópio DO; Almeida IC; Torrecilhas AC; Cardoso JE; Teyton L; Travassos LR; Bendelac A; Gazzinelli RT
J Immunol; 2002 Oct; 169(7):3926-33. PubMed ID: 12244192
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a natural human antibody with anti-galactosyl(alpha 1-2)galactose specificity that is present at high titers in chronic Trypanosoma cruzi infection.
Avila JL; Rojas M; Velazquez-Avila G
Am J Trop Med Hyg; 1992 Oct; 47(4):413-21. PubMed ID: 1279994
[TBL] [Abstract][Full Text] [Related]
8. Reactivity of chagasic antigal antibodies with noninfected cells treated with Trypanosoma cruzi secreted/excreted antigens.
Yokoyama-Yasunaka JK; Piazza RM; Umezawa ES; Stolf AM
J Clin Lab Anal; 1998; 12(2):108-14. PubMed ID: 9524295
[TBL] [Abstract][Full Text] [Related]
9. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies.
Almeida IC; Milani SR; Gorin PA; Travassos LR
J Immunol; 1991 Apr; 146(7):2394-400. PubMed ID: 1706399
[TBL] [Abstract][Full Text] [Related]
10. Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease.
Gazzinelli RT; Galvao LM; Krautz G; Lima PC; Cancado JR; Scharfstein J; Krettli AU
Am J Trop Med Hyg; 1993 Nov; 49(5):625-35. PubMed ID: 8250103
[TBL] [Abstract][Full Text] [Related]
11. Anti-alpha-galactosyl antibodies in chagasic patients. Possible biological significance.
Milani SR; Travassos LR
Braz J Med Biol Res; 1988; 21(6):1275-86. PubMed ID: 2471563
[TBL] [Abstract][Full Text] [Related]
12. Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies.
Gazzinelli RT; Pereira ME; Romanha A; Gazzinelli G; Brener Z
Parasite Immunol; 1991 Jul; 13(4):345-56. PubMed ID: 1717927
[TBL] [Abstract][Full Text] [Related]
13. Immunogenic Gal alpha 1----3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania.
Avila JL; Rojas M; Galili U
J Immunol; 1989 Apr; 142(8):2828-34. PubMed ID: 2467941
[TBL] [Abstract][Full Text] [Related]
14. Trypanosoma cruzi surface mucins with exposed variant epitopes.
Pollevick GD; Di Noia JM; Salto ML; Lima C; Leguizamón MS; de Lederkremer RM; Frasch AC
J Biol Chem; 2000 Sep; 275(36):27671-80. PubMed ID: 10843987
[TBL] [Abstract][Full Text] [Related]
15. Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies.
Pereira-Chioccola VL; Acosta-Serrano A; Correia de Almeida I; Ferguson MA; Souto-Padron T; Rodrigues MM; Travassos LR; Schenkman S
J Cell Sci; 2000 Apr; 113 ( Pt 7)():1299-307. PubMed ID: 10704380
[TBL] [Abstract][Full Text] [Related]
16. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
Laucella SA; de Titto EH; Segura EL
Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983
[TBL] [Abstract][Full Text] [Related]
17. [Partial purification and use of Trypanosoma cruzi glycosidic fractions for Chagas disease diagnosis].
De Lima Rivero AR; Farías Tamoy MN; Tortolero Leal E; Navarro Aguilera MC; Contreras Alvarez VT
Acta Cient Venez; 2001; 52(4):235-47. PubMed ID: 11915441
[TBL] [Abstract][Full Text] [Related]
18. A galactosyl(alpha 1-3)mannose epitope on phospholipids of Leishmania mexicana and L. braziliensis is recognized by trypanosomatid-infected human sera.
Avila JL; Rojas M
J Clin Microbiol; 1990 Jul; 28(7):1530-7. PubMed ID: 1696285
[TBL] [Abstract][Full Text] [Related]
19. Early, intermediate, and late acute stages in Chagas' disease: a study combining anti-galactose IgG, specific serodiagnosis, and polymerase chain reaction analysis.
Antas PR; Medrano-Mercado N; Torrico F; Ugarte-Fernandez R; Gómez F; Correa Oliveira R; Chaves AC; Romanha AJ; Araújo-Jorge TC
Am J Trop Med Hyg; 1999 Aug; 61(2):308-14. PubMed ID: 10463685
[TBL] [Abstract][Full Text] [Related]
20. Galactofuranose-containing glycoconjugates of epimastigote and trypomastigote forms of Trypanosoma cruzi.
Golgher DB; Colli W; Souto-Padrón T; Zingales B
Mol Biochem Parasitol; 1993 Aug; 60(2):249-64. PubMed ID: 8232416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
